Living on the SERMO social network, Drug Ratings is the first and only global peer-to-peer drug review system provided exclusively from verified licensed physicians. Drug Ratings is the world’s largest dataset of physician perceptions on drugs. Drugs are rated according to their efficacy, safety, tolerability, accessibility, and adherence. Reviews often also include commentary based on doctors’ real-world experiences.
Ratings was developed by SERMO and our very own physicians. The statistical methodology behind Ratings was developed and verified independently by biostatistics consultants led by Lee-Jen Wei (Blue Null Consulting Group).
When it comes to drugs, official clinical trial data and product monographs are one half of the story; commentary and reviews are the other half. Combined with official sources of information, SERMO Drug Ratings offers a more holistic and deeper way to evaluate drugs, and can help doctors make more informed prescribing decisions. Drug Ratings ushers in a new dimension of transparency to healthcare and is a new window into the minds of physicians.
As with everything on the SERMO social network, only verified and licensed physicians can participate and rate. When SERMO members read reviews of drugs they know that the information was sourced exclusively from the most relevant audience it could be – their own.
Drug Ratings is an entirely new resource for physicians, but it is built on a well-understood concept. Consumers use star-ratings and reviews to help them understand what to expect from products, restaurants, entertainment, and more. Now, like a consumer can turn to reviews to inform their buying decisions, doctors can combine personal experience from their peers with official information to inform their prescribing decisions.
Until recently, peer perception of drugs has been a black box for physicians. Official manufacturer information offers very little visibility into how drugs are accepted by physicians or used by patients, or how accessible the drugs actually are. A massive amount of such official information is aimed at doctors, though none of it includes their experiences.
Drug Ratings is democratized data: reviews are collected from a broad base of real-world prescribers in real time, and over time. Including hundreds of thousands of data points on perceptions, challenges, and other real experiences in one place, Drug Ratings is an unprecedented bank of peer-supplied healthcare data.
Reviews include aggregate numerical scores for drugs and personal insights from peers. The quantitative and qualitative elements of each review provide revolutionary transparency and balanced assessments of how physicians from around the corner and around the globe feel about drugs, and lend confidence when selecting between multiple drug options.
This is particularly important when doctors are considering prescribing new drugs for the first time, or established drugs for newly approved indications. Never before has it been possible to quantify other doctors’ real world experiences or rapidly access first-hand information at scale about such usage, which has slowed when valuable new discoveries are adopted. Drug Ratings supports the adoption of new drugs by allowing early adopters of drugs to share their knowledge quickly, broadly, and directly to their colleagues.
“Imagine the power of 1000 prescribers, sharing their drug experience, all this at the tip of your hand when you need it most. I am proud to be part of a team of distinguished physicians that is improving healthcare and providing state of the art technology to accomplish this mission.”
“SERMO Drug Rating is unique, in that it solicits input from clinicians who have broad experience in evaluating the performance of various drugs, including assessing patient acceptance/compliance, efficacy, safety/tolerability, and cost.”
“A lot of the drug information we get is from the company reps and advertising. It is so valuable to get information from actual prescribers who have real-world experience with different medications, some of which may be very similar. Details and knowledge about efficacy, dosing, and combining with other medications is also helpful... Drug reps often tell us how well their medications work and how reasonable the out-of-pocket cost is for our patients, but the reality is often quite different.”
“In an era where most physicians are swamped with information, SERMO Drug Ratings offer a rare chance to hear what colleagues think about an agent that they have used. So many drugs, so little time, so here's a chance to get inside information quickly.”
“The Drug Ratings Database kickoff represented the largest collaboration by physicians globally. Drug Ratings bring together 600,000 physicians in 30 different countries to connect insights and formulate a value-based database that will help drive better outcomes. Finishing this database is one of the most important global collaboration in the history of medicine. SERMO efforts to put together a database will revolutionize real world medicine!”
“In the past, clinical trial data proof was a sufficient foundation for product success in oncology, unlike today where compelling evidence of treatment value is the rule… SERMO’s efforts to put together a database will revolutionize real world medicine! A non-biased grassroots database whose overall focus is to allow doctors to collaborate and share in a value-based database of treatment innovation without outside influences like payers and/or policy makers.”
“One of the things SERMO is valuable for is to crowdsource opinions without the external systems like payers and admins. Drug Ratings provides that.”
“I definitively see myself using this – I work in Urgent Care, and there are a lot of drugs that I don’t know at all. They’re releasing drugs at such a fast pace and I won’t know what the hell this is. Google only gets you so far, I don’t know if it’s a good drug for this or not – to know if other doctors I know are using and trusting.”
While the SERMO social network has formally launched in 30 countries, doctors from anywhere on the planet are encouraged to take full advantage of Drug Ratings. This was built by doctors, for real doctors – no matter where they are practicing.
Doctors around the world share their experiences and collectively drive real-world medicine forward on SERMO. They engage with each other honestly, in part because they are able to speak anonymously and know that every other person in the network has met strong verification standards. They respect each other’s real-world experiences, and understand that medicine is strengthened when all physicians are given an equal voice in the conversation. There is no other network that has both the protection and vibrancy needed to build a platform like this.
Simply head to app.sermo.com to log-in or create an account! Drug Ratings is available from the home page of SERMO.
More than 90 specialties and subspecialties are currently providing reviews for drugs in Drug Ratings.
We are building the first drug database by doctors, for doctors where they can rate over 10,000 drugs including prescriptions drugs, branded generics, and more.
Ratings was developed by SERMO and our very own physicians. The statistical methodology behind Ratings was developed and verified independently by biostatistics consultants led by Lee-Jen Wei (Blue Null Consulting Group). For more information about the methodology please click here.
For other questions about Drug Ratings, please write us at email@example.com.Click Here to Join SERMO